Edwards Lifesciences Corporation (NYSE: EW) announced that one-year results on patients treated in the single-arm, prospective, global, multi-center TRISCEND study of the company’s EVOQUE …
https://finance.yahoo.com/news/edwards-announces-one-data-transfemoral-152500329.html